Geeta D.Pharma FAQs
Ques. Is D.Pharma at Geeta University approved by the Pharmacy Council of India (PCI)?
Ans. Yes, the D.Pharma programme is offered through Geeta Institute of Pharmacy (GIP), which is approved by the Pharmacy Council of India (PCI), New Delhi. The institute is affiliated to Geeta University from session 2022-23 onwards. This approval ensures that the course meets national standards and that graduates are recognized across India for employment and further studies.
Ques. Can D.Pharma graduates from Geeta University pursue B.Pharma through lateral entry?
Ans. Yes, D.Pharma graduates can pursue B.Pharma through lateral entry, gaining direct admission to the 2nd year of the B.Pharma programme. This is a recognised pathway under PCI and AICTE guidelines, allowing D.Pharma graduates to upgrade their qualification without repeating the first year. This lateral entry option makes D.Pharma an excellent stepping stone for students who want to pursue higher pharmaceutical education.
Ques. What are the career options available after completing D.Pharma from Geeta University?
Ans. D.Pharma graduates have diverse career opportunities in the healthcare and pharmaceutical sectors. They can work as Registered Pharmacists in hospitals, retail pharmacies, and community health centres. Other career options include Medical Representative, Pharmaceutical Sales Executive, Pharmacy Technician, Quality Control Assistant, and Process Technician in pharmaceutical manufacturing. Top recruiters include Apollo Pharmacy, MedPlus, Cipla, Sun Pharma, Fortis Hospitals, and government health departments. The course also opens doors to entrepreneurship, allowing graduates to establish their own pharmacies or pharmaceutical businesses.
Ques. What is the difference between direct admission and HSTES counselling for D.Pharma at Geeta University?
Ans. Direct admission at Geeta University is merit-based and conducted through the university's own admissions portal. Candidates apply directly, undergo a personal interaction/interview, and receive admission offers based on their qualifications and performance. HSTES (Haryana State Technical Education Society) counselling, on the other hand, is a state-level process where candidates register on the HSTES portal and participate in online counselling rounds. Both pathways lead to admission at Geeta University, but HSTES counselling follows a centralized state-level process with specific dates and procedures. Students can choose either route based on their preference.
Ques. How much does the D.Pharma course cost at Geeta University, and are there payment options available?
Ans. The total cost of the D.Pharma course at Geeta University is Rs. 2,33,500 for the complete 2-year duration. This includes tuition fees (Rs. 1,80,000), admission fee (Rs. 10,000), examination fees (Rs. 10,000), other annual charges (Rs. 20,000), uniform charges (Rs. 12,000), and application fee (Rs. 1,500). The university offers flexible payment options through EMI (Equated Monthly Installment) via third-party bank tie-ups, allowing students to spread the cost over the course duration. Additionally, various scholarships are available that can reduce the tuition fee by 10% to 100% based on merit, NEET scores, sports achievements, or social responsibility criteria.
Ques. What practical training and industry exposure does the D.Pharma programme at Geeta University provide?
Ans. The D.Pharma programme at Geeta University emphasizes practical learning through well-equipped laboratories with modern equipment, industrial visits to pharmaceutical manufacturing units, and partnerships with hospitals for clinical pharmacy training. Students receive hands-on training in drug dispensing, prescription interpretation, and community pharmacy practice. The curriculum includes practical lab sessions as a major component, ensuring students gain real-world pharmaceutical experience. These practical exposures prepare graduates for immediate employment in hospitals, retail pharmacies, and pharmaceutical companies, making them job-ready upon graduation.
Comments